Moving Ahead A Closer Look At Evrysdi

Thursday, August 25, 6:00 PM EDT

Online webinar

To facilitate the registration process, Genentech and its partners have to collect your name and contact information. You can find additional information about our privacy practices at https://www.gene.com/privacy-policy

*Indicates a required field

First Name*

Last Name*

Email Address*

Confirm Email Address*

Phone Number*

Address 1

Address 2

State

City

Zip Code*

What best describes you?*

Will any guests be participating in the event with you? How many?

For additional Genentech support services:

I wish to receive information that may be of interest to me from Genentech and its afﬁliates about products, services, including co-pay assistance or other patient support, opportunities to participate in surveys or provide feedback, or other topics (including information about diseases or conditions). I may be contacted by mail or email using the information I’ve provided. By asking to receive this information, I understand my personally identiﬁable information will be used and disclosed by Genentech, its successors, its agents, and as otherwise required by law. I understand providing this agreement is voluntary and plays no role in getting my medicine. I also understand that I may opt out of receiving this information at any time by calling 877-436-3683.

By checking this box, I consent to receive autodialed calls and text messages, which may include marketing communications, from and on behalf of Genentech at the phone number(s) provided regarding Evrysdi Community Educational Events. I understand that consent is not a requirement of any purchase or enrollment. Message frequency may vary. Message and data rates may apply. I may opt out at any time by texting STOP or calling 877-436-3683. I am also agreeing to the Privacy Policy and SMS Terms & Conditions.

Cancel

Location

Virtual Program

Speaker(s)

Theresa Coia

Community Guest:

Jim

Partnership and Access Liaison (PAL):

Theresa Coia

Before taking Evrysdi, tell your healthcare provider about all of your medical conditions, including if you:

are pregnant or plan to become pregnant. If you are pregnant, or are planning to become pregnant, ask your healthcare provider for advice before taking this medicine. Evrysdi may harm your unborn baby.
are a woman who can become pregnant:

Before you start your treatment with Evrysdi, your healthcare provider may test you for pregnancy. Because Evrysdi may harm your unborn baby, your healthcare provider will decide if taking Evrysdi is right for you during this time
Talk to your healthcare provider about birth control methods that may be right for you. Use birth control while on treatment and for at least 1 month after stopping Evrysdi

are an adult male planning to have children: Evrysdi may affect a man’s ability to have children (fertility). If this is of concern to you, make sure to ask a healthcare provider for advice
are breastfeeding or plan to breastfeed. It is not known if Evrysdi passes into breast milk and may harm your baby. If you plan to breastfeed, discuss with your healthcare provider about the best way to feed your baby while on treatment with Evrysdi

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine
You should receive Evrysdi from the pharmacy as a liquid that can be given by mouth or through a feeding tube. The liquid solution is prepared by your pharmacist. If the medicine in the bottle is a powder, do not use it. Contact your pharmacist for a replacement
Avoid getting Evrysdi on your skin or in your eyes. If Evrysdi gets on your skin, wash the area with soap and water. If Evrysdi gets in your eyes, rinse your eyes with water
The most common side effects of Evrysdi include:

For later-onset SMA:

fever
diarrhea
rash

For infantile-onset SMA:

fever
diarrhea
rash
runny nose, sneezing, sore throat, and cough (upper respiratory infection)
lung infection
constipation
vomiting

These are not all of the possible side effects of Evrysdi. For more information on the risk and benefits profile of Evrysdi, ask your healthcare provider or pharmacist.

You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at 1-888-835-2555.

Please see full Prescribing Information for additional Important Safety Information.

Evrysdi is a prescription medicine used to treat spinal muscular atrophy (SMA) in adults and children 2 months of age and older.

It is not known if Evrysdi is safe and effective in children under 2 months of age.